Pierre-Louis Lezotre

International Cooperation, Convergence and Harmonization of Pharmaceutical Regulations (eBook, ePUB)

A Global Perspective

• Format: ePub

Produktbeschreibung

International Cooperation, Convergence and Harmonization of Pharmaceutical Regulations: A Global Perspective provides the current status of the complex and broad phenomenon of cooperation, convergence and harmonization in the pharmaceutical sector (Part I), thoroughly evaluates its added value and its critical parameters and influencing factors (Part II) in order to recommend actions and measures to support the next steps for cooperation, convergence and harmonization (Part III). All of these recommendations in the book support the establishment of a better coordinated global pharmaceutical system which represents the best realistic alternative to fulfill the objective to establish a global coalition of regulators and to respond to an increased demand to further cooperation in the pharmaceutical sector. This proposed framework, which leverages all of the ongoing positive cooperation initiatives and uses as foundations all of the numerous harmonization projects developed over the years, presents advantages for all stakeholders and would definitively have significant added value to the promotion and protection of global public health.

• The status of all major worldwide harmonization and cooperation initiatives (at bilateral, regional, and global levels)
• The value of cooperation in the pharmaceutical sector and the driving factors behind harmonization
• The proposition of a structure for the global pharmaceutical system and timely recommendations for enhancing international cooperation, as well as further discussion and policy changes in this area

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Elsevier Science & Techn.
• Seitenzahl: 376
• Erscheinungstermin: 5. Dezember 2013
• Englisch
• ISBN-13: 9780128005699
• Artikelnr.: 40289376

Autorenporträt

Dr. Pierre-Louis Lezotre specializes in global regulatory strategy, and is recognized for his passion and expertise

on international cooperation, convergence, and harmonization of regulations for pharmaceutical

and biotechnology products. He has worked in different cultural environments and lived in

both Europe and the United States.

Dr. Lezotre studied biology (University of Sciences, Saint-Etienne, France)

and drug development (University of Pharmacy, Montpellier, France) from

1992 to 1998. He then received his Master in Regulatory Sciences in 1999 (University

of Pharmacy, Lille, France). He also recently completed his PhD in Law with honors (Doctoral

School of "Law, Politics and Management,¿ University of Law, Lille, France).

Since 1998, Dr. Lezotre has worked for several international pharmaceutical and biotechnology

companies, with increasing levels of responsibility. He has served as a regional and

then global regulatory leader for small molecule and biologic/biotech programs in various

stages of research and development (from early discovery to life cycle management). He

successfully led many global regulatory teams in supporting global registrations of major

products and numerous development projects in several therapeutic areas, including

dermatology, urology, neurology, and pain. He has been responsible for communications

with worldwide Drug Regulatory Authorities and has also worked with external partners/

companies through co-development agreements and business development programs.

Dr. Lezotre has recently been invited to teach courses on international regulation in the

Regulatory Sciences programs of the University of Southern California (USC).

Inhaltsangabe

PrefaceAbout the AuthorForeword by Stuart WalkerIntroduction
Part I: State of Play and Review of Major Cooperation Initiatives Part II:
Value and Influencing Factors of Cooperation, Convergence and Harmonization
in the Pharmaceutical SectorPart III: Recommendations to Support the Next
Phase of International Cooperation, Convergence and Harmonization in the
Pharmaceutical DomainConclusion